Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 30,447 | 28,005 | 24,068 | 17,372 | 14,084 |
| Cost of Goods | 761 | 513 | 637 | 274 | 337 |
| Gross Profit | 29,686 | 27,492 | 23,431 | 17,098 | 13,747 |
| Operating Expenses | 45,651 | 48,501 | 31,012 | 25,476 | 32,781 |
| Operating Income | -15,204 | -20,496 | -6,944 | -8,104 | -18,697 |
| Interest Expense | 333 | 695 | 2,922 | 4,398 | 2,627 |
| Other Income | 2,543 | 165,530 | -15,646 | 12,136 | -7,703 |
| Pre-tax Income | -12,994 | 144,339 | -25,512 | -366 | -29,028 |
| Income Tax | -10,525 | 38,761 | 15 | -40,021 | 0 |
| Net Income Continuous | -2,469 | 105,578 | -25,527 | 39,655 | -29,027 |
| Net Income | $-2,469 | $105,578 | $-25,527 | $39,655 | $-29,027 |
| EPS Basic Total Ops | -0.19 | 2.95 | -0.73 | 1.46 | -0.97 |
| EPS Basic Continuous Ops | -0.19 | 2.95 | -0.73 | 1.46 | -0.97 |
| EPS Diluted Total Ops | 0.80 | 1.78 | -0.73 | 1.32 | 0.43 |
| EPS Diluted Continuous Ops | 0.08 | 2.47 | -0.73 | 1.31 | -0.98 |
| EBITDA(a) | $-10,666 | $-11,740 | $-2,679 | $-5,823 | $-16,326 |